 CARLSBAD, Calif.--BUSINESS WIRE--Ra Medical Systems, Inc. NYSE American: RMED, a medical device company focused on commercializing excimer laser systems to treat vascular and dermatological diseases, announces an increase in enrollment in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease PAD. A total of 42 subjects have been enrolled as of April 19, 2021. We are e 